Proteomics Study Guide

📖 Core Concepts Proteomics – large‑scale study of all proteins (the proteome) in a cell, tissue, or organism, including their amounts, structures, modifications, and interactions. Proteome – complete set of protein species present at a given time; highly dynamic across cell types, developmental stages, and physiological conditions. Post‑translational modifications (PTMs) – chemical changes after translation (e.g., phosphorylation, ubiquitination, glycosylation) that modulate activity, localization, or stability. Mass Spectrometry (MS) – the primary analytical engine for proteomics; measures mass‑to‑charge ratios of ionized peptides/proteins to infer sequence and PTMs. Bottom‑up (shotgun) proteomics – proteins are enzymatically digested (usually with trypsin) into peptides before MS analysis. Top‑down proteomics – intact proteins are introduced to the mass spectrometer, preserving proteoform information (isoforms, PTM patterns). Antibody‑based detection – ELISA, Western blot, and protein microarrays rely on specific antibodies (or alternatives like nanobodies, aptamers) to capture/visualize proteins. Quantitative strategies – stable‑isotope labeling (e.g., ICAT, SILAC), label‑free intensity‑based methods, spectral counting, and targeted SRM/PRM. Proteogenomics – integration of MS‑derived peptide evidence with genomic/transcriptomic data to refine gene annotation and discover novel coding regions. Single‑cell proteomics – isolation of individual cells, ultra‑sensitive sample prep, peptide labeling, and high‑resolution MS to measure protein covariation and heterogeneity. Plasma proteome challenges – >10‑order dynamic range (albumin ≈ 10 g L⁻¹ vs cytokines ≈ pg mL⁻¹); requires depletion or enrichment strategies. --- 📌 Must Remember mRNA ≠ protein abundance – translation efficiency and degradation rates decouple the two. PTMs are invisible to genome sequencing – only proteomics can directly capture them. Mass spectrometry = gold standard for unbiased protein identification and PTM mapping. Dynamic range of plasma ≈ 10¹⁰; low‑abundance biomarkers are often masked by albumin and immunoglobulins. Targeted proteomics (SRM/PRM) → higher reproducibility, but lower breadth than shotgun approaches. Stable‑isotope labeling provides accurate relative quantification between two (or more) conditions. Isoforms & proteoforms arise from alternative splicing, PTMs, and complex formation—single peptide may map to multiple proteins. Bottom‑up loses proteoform context; top‑down preserves it but needs higher‑resolution instruments. Single‑cell data reveal protein covariation that indicates complex formation, cell‑cycle stage, or drug‑resistance priming. --- 🔄 Key Processes Shotgun Bottom‑up Workflow Cell lysis → protein extraction Reduction/alkylation → trypsin digestion → peptide mixture Liquid‑chromatography (LC) separation Tandem MS (MS/MS) for peptide sequencing Database search (UniProt, PROSITE) → protein identification & PTM assignment Targeted SRM/PRM (Selected/Parallel Reaction Monitoring) Choose signature peptides (unique, stable) Spike in isotopically‑labeled standards (optional) LC‑MS acquisition with predefined transition monitoring Quantify using peak area ratios → high‑precision reproducible data ELISA (Enzyme‑Linked Immunosorbent Assay) Coat plate with capture antibody Add sample → antigen binds Add detection antibody linked to enzyme Add substrate → colorimetric/fluorescent readout → concentration via standard curve Single‑Cell Proteomics Workflow Isolate single cell (FACS, microfluidics) Lysis & protein denaturation in nanoliter volume Minimal‑loss digestion, isobaric labeling (e.g., TMT) Nano‑LC‑MS/MS with ultra‑high‑sensitivity instrument Data analysis → protein copy‑number estimation, covariation matrices Plasma Proteome Profiling (high‑throughput) Deplete high‑abundance proteins (e.g., albumin) or use affinity capture Digest → label (if quantitative) LC‑MS/MS with accurate mass‑time (AMT) tagging for rapid identification --- 🔍 Key Comparisons Proteomics vs. Transcriptomics Proteomics: measures actual protein molecules; captures PTMs, isoforms, degradation. Transcriptomics: measures RNA; often poor correlation with protein levels. Bottom‑up vs. Top‑down Bottom‑up: higher coverage, easier sample prep, loses proteoform context. Top‑down: retains full proteoform information, lower throughput, requires high‑resolution MS. Label‑free vs. Stable‑Isotope Labeling Label‑free: intensity‑based; simpler, good for large cohorts, but higher run‑to‑run variance. Isotope labeling: accurate relative quant; limited to 2–8 samples per experiment, more costly. Shotgun (untargeted) vs. Targeted Proteomics Shotgun: discovery‑oriented, stochastic peptide sampling, lower reproducibility. Targeted: pre‑selected peptides, high reproducibility, limited to known targets. Antibody‑based vs. Antibody‑free (MS) detection Antibody‑based: high specificity, limited to available antibodies, generally single‑plex or modest multiplex. MS‑based: unbiased, multiplexed thousands of proteins, can detect PTMs directly. --- ⚠️ Common Misunderstandings “mRNA level predicts protein amount.” – Translation efficiency and protein half‑life break this link. “Genomics captures all functional information.” – PTMs, isoforms, and degradation are invisible to DNA alone. “More peptides = better quantification.” – Shared peptides can inflate false identifications; stochastic sampling reduces reproducibility. “Plasma proteins are easy to quantify because blood is readily available.” – Extreme dynamic range demands depletion/enrichment; low‑abundance biomarkers are often missed. “Single‑cell proteomics is just bulk proteomics on a smaller scale.” – Heterogeneity and technical noise require distinct statistical handling. --- 🧠 Mental Models / Intuition Proteome as a “living snapshot” – imagine a photo of a bustling city: different neighborhoods (cell types) show different traffic (protein levels) at different times (developmental stages). Mass spectrometer as a “digital scale” – each ion’s mass‑to‑charge ratio is a weight; the pattern of weights uniquely identifies the protein/peptide. Bottom‑up = “cutting a book into pages” – you read individual pages (peptides) to infer the story (protein). Top‑down = “reading the whole book” – you see the complete narrative, including footnotes (PTMs). PTM as “post‑it notes” on a protein – they modify the protein’s behavior without changing the underlying sequence. --- 🚩 Exceptions & Edge Cases Glycosylated peptides often resist trypsin cleavage → may need alternative enzymes or enrichment. Highly abundant proteins (e.g., albumin) can dominate MS spectra, suppressing detection of low‑abundance species. Isoform‑specific peptides may be absent; shared peptides lead to ambiguous protein inference. Targeted assays improve reproducibility but cannot discover unexpected PTMs. Label‑free quantification may be unreliable when run‑to‑run chromatography drift is high. --- 📍 When to Use Which | Goal | Recommended Method | Why | |------|-------------------|-----| | Discover unknown proteins / PTMs | Bottom‑up shotgun LC‑MS/MS | Broad coverage, unbiased | | Quantify a predefined panel of 10–50 proteins across many samples | Targeted SRM/PRM or multiplexed ELISA | High precision, scalable | | Study protein isoforms or proteoforms | Top‑down MS or PTM‑enriched bottom‑up | Preserves modification pattern | | Compare two conditions with high accuracy | Stable‑isotope labeling (SILAC, TMT) | Internal standard corrects variability | | Profile plasma biomarkers | Depletion of high‑abundance proteins + LC‑MS/MS with AMT tagging | Mitigates dynamic‑range problem | | Investigate cell‑to‑cell heterogeneity | Single‑cell proteomics workflow (nano‑LC‑MS) | Captures covariation, rare states | | Map protein–protein interactions | Affinity purification‑MS or yeast two‑hybrid | Direct interaction evidence | | Validate a candidate drug target | Chemoproteomics / thermal shift assay | Confirms target engagement in native context | --- 👀 Patterns to Recognize Mass shift of +79.966 Da on serine, threonine, or tyrosine → phosphorylation. Mass shift of +114.042 Da (diglycine remnant) → ubiquitination after trypsin digestion. Consistent up‑regulation of a set of peptides across replicates → likely true biological change, not stochastic sampling. Co‑elution of multiple peptides from the same protein in a 2‑D gel or LC map → indicates a protein complex or PTM variant. High spectral counts for a peptide despite low intensity → possible peptide‑specific ionization bias; verify with other peptides. --- 🗂️ Exam Traps Distractor: “Because the genome is constant, proteomics is unnecessary.” – Wrong; PTMs and protein turnover create functional diversity absent from the genome. Distractor: “Label‑free quantification is always less accurate than isotope labeling.” – Not always; with robust normalization and low instrument drift, label‑free can be comparable. Distractor: “ELISA measures protein activity directly.” – ELISA detects presence/quantity; activity assays require functional readouts. Distractor: “Shotgun proteomics provides perfectly reproducible data.” – Stochastic peptide sampling leads to run‑to‑run variability; targeted methods improve reproducibility. Distractor: “All plasma proteins are equally accessible for detection.” – Dynamic range and binding proteins (e.g., albumin) hide many low‑abundance biomarkers. Distractor: “A single peptide identification confirms a protein’s presence.” – Shared peptides may belong to multiple proteins; need at least two unique peptides for high confidence. ---